Carna Biosciences Overview

  • Founded
  • 2003
  • Status
  • Public
  • Employees
  • 68
  • Stock Symbol
  • 4572
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $8.90
  • (As of Thursday Closing)

Carna Biosciences General Information


Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • BMA 3F 1-5-5 Minatojima-Minamimachi
  • Chuo-ku
  • Kobe, 650-0047
  • Japan
+81 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Carna Biosciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.90 $8.86 $7.81 - $15.64 $118M 13.3M 89.3K -$1.22

Carna Biosciences Financials Summary

In Thousands,
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 95,942 105,510 187,442 78,894
Revenue 8,579 10,614 29,419 6,833
EBITDA (10,140) 8,533 (10,716)
Net Income (15,255) (10,405) 7,597 (10,961)
Total Assets 37,619 46,885 49,373 16,041
Total Debt 2,456 4,167 6,692 6,222
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Carna Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Carna Biosciences‘s full profile, request access.

Request a free trial

Carna Biosciences Patents

Carna Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017354372-A1 Furanone derivates and methods of use thereof Abandoned 04-Nov-2016 0000000000
CA-3042849-A1 Furanone derivates and methods of use thereof Pending 04-Nov-2016 000000000
US-20200055848-A1 Furanone derivates and methods of use thereof Abandoned 04-Nov-2016 0000000000
JP-WO2018079629-A1 Novel pyrimidine derivatives with antimalarial activity Granted 26-Oct-2016 0000000000
US-20190345154-A1 Novel pyrimidine derivative having antimalarial activity Granted 26-Oct-2016 C07D471/04
To view Carna Biosciences’s complete patent history, request access »

Carna Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Kohichiro Yoshino Founder, Owner, Chief Executive Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Carna Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carna Biosciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Oct-2013 0000000000 00.00 Other Healthcare Services
To view Carna Biosciences’s complete acquisitions history, request access »

Carna Biosciences Subsidiaries (1)

Company Name Industry Location Founded
000000 Other Healthcare Services Kobe, Japan 0000
To view Carna Biosciences’s complete subsidiaries history, request access »